Virginia Retirement Systems Et Al Karyopharm Therapeutics Inc. Transaction History

Virginia Retirement Systems Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	SELL	$1.79 - $4.59 $72,674 - $186,354	-40,600 Reduced 30.62%	92,000 $164,000
Q1 2023 Jul 11, 2023	BUY	$2.84 - $3.92 $117,292 - $161,896	41,300 Added 45.24%	132,600 $515,000
Q4 2022 May 17, 2023	BUY	$2.48 - $5.93 $174,096 - $416,286	70,200 Added 332.7%	91,300 $310 Million
Q3 2022 May 16, 2023	BUY	$4.08 - $5.82 $86,088 - $122,802	21,100 New	21,100 $115 Million
Q1 2022 Apr 21, 2022	SELL	$5.91 - $14.38 $254,721 - $619,778	-43,100 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$5.21 - $8.61 $412,632 - $681,912	-79,200 Reduced 64.76%	43,100 $277,000
Q3 2021 Oct 21, 2021	BUY	$4.45 - $10.63 $439,660 - $1.05 Million	98,800 Added 420.43%	122,300 $712,000
Q2 2021 Aug 13, 2021	BUY	$8.11 - $11.11 $190,585 - $261,085	23,500 New	23,500 $243,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $64.6M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.